Results 191 to 200 of about 19,182 (246)
Cholinergic Mechanisms in Gastrointestinal Neoplasia. [PDF]
Sampaio Moura N+5 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Muscarinic Acetylcholine Receptor M5
Definitions, 2020Muscarinic acetylcholine receptor M5 (532 aa, ~60 kDa) is encoded by the human CHRM5 gene. This protein plays a role in both acetylcholine binding and G protein-coupled receptor signaling.
semanticscholar +2 more sources
Identification of a Novel Allosteric Site at the M5 Muscarinic Acetylcholine Receptor
The M5 muscarinic acetylcholine receptor (mAChR) has emerged as an exciting therapeutic target for the treatment of addiction and behavioral disorders.
Wessel A. C. Burger+13 more
semanticscholar +3 more sources
The Muscarinic Acetylcholine Receptor M5: Therapeutic Implications and Allosteric Modulation.
ACS Chemical Neuroscience, 2018The muscarinic acetylcholine receptor (mAChR) subtype 5 (M5) was the most recent mAChR to be cloned and has since emerged as a potential therapeutic target for a number of indications.
Aaron M. Bender+2 more
semanticscholar +4 more sources
Activation mechanism of the M5 muscarinic acetylcholine receptor.
Biophysical Journal, 2023Lee Roy+3 more
semanticscholar +2 more sources
An Improved Orthosteric Antagonist of the M5 Muscarinic Acetylcholine Receptor
Synfacts, 2022semanticscholar +2 more sources
Cloning and expression of the human and rat m5 muscarinic acetylcholine receptor genes
Neuron, 1988The human and rat genes for a fifth muscarinic receptor have been cloned and expressed in mammalian cells. The 532 amino acid human protein has 89% sequence identity to the 531 amino acid rat protein and is most closely related to the m3 receptor. Both proteins are encoded by single exons.
T. Bonner+3 more
semanticscholar +4 more sources
Journal of Medicinal Chemistry, 2022
The muscarinic acetylcholine receptor (mAChR) subtype 5 (M5) represents a novel potential target for the treatment of multiple addictive disorders, including opioid use disorder.
Aaron T Garrison+25 more
semanticscholar +1 more source
The muscarinic acetylcholine receptor (mAChR) subtype 5 (M5) represents a novel potential target for the treatment of multiple addictive disorders, including opioid use disorder.
Aaron T Garrison+25 more
semanticscholar +1 more source
Discovery of M5 Muscarinic Acetylcholine Receptor Antagonists: 1‐Methyl‐4‐Phenylpiperidine Analogs
Na-Ra Lee+4 more
semanticscholar +2 more sources
Characterization of methanthelinium binding and function at human M1–M5 muscarinic acetylcholine receptors [PDF]
Firstly, it was determined whether methanthelinium bromide (MB) binds to human M1-M5 (hM1-hM5) muscarinic acetylcholine receptors in comparison to the classical muscarinic antagonist N-methylscopolamine (NMS). [3H]NMS dissociation binding experiments revealed an allosteric retardation of dissociation at 100 μM of MB ranging from none in hM3 to 4.6-fold
Matthias Irmen+3 more
openaire +2 more sources